Status: current, Primitive. Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3445326014 | Olanzapine embonate (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3445327017 | Olanzapine embonate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 5098084017 | Olanzapine pamoate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olanzapine embonate | Is a | Drug allergen | false | Inferred relationship | Some | ||
| Olanzapine embonate | Is a | Dibenzoxazepine compound | true | Inferred relationship | Some | ||
| Olanzapine embonate | Is modification of | Olanzapine | true | Inferred relationship | Some | ||
| Olanzapine embonate | Is a | Anti-psychotic agent | true | Inferred relationship | Some | ||
| Olanzapine embonate | Is a | Olanzapine | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olanzapine embonate monohydrate | Is modification of | True | Olanzapine embonate | Inferred relationship | Some | |
| Olanzapine (as olanzapine embonate) 405 mg powder for prolonged-release suspension for injection vial | Has precise active ingredient | True | Olanzapine embonate | Inferred relationship | Some | 1 |
| Olanzapine (as olanzapine embonate) 300 mg powder for prolonged-release suspension for injection vial | Has precise active ingredient | True | Olanzapine embonate | Inferred relationship | Some | 1 |
| Olanzapine (as olanzapine embonate) 210 mg powder for prolonged-release suspension for injection vial | Has precise active ingredient | True | Olanzapine embonate | Inferred relationship | Some | 1 |
| Olanzapine embonate monohydrate | Is a | False | Olanzapine embonate | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR